MLEC Moolec Science SA - Ordinary Shares
MLEC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
MLEC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Financial Health Debt, liquidity, solvency — balance sheet strength
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
MLEC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
- Strong Buy 2 28.6%
- Buy 4 57.1%
- Hold 1 14.3%
- Sell 0 0.0%
- Strong Sell 0 0.0%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| Dec. 31, 2024 | $-9.00 | $-9.18 | 0.18% |
| Sept. 30, 2024 | $-7.50 | $-10.71 | 3.2% |
| June 30, 2024 | $-10.50 | $-9.18 | -1.3% |
| March 31, 2024 | $-6.00 | $-10.71 | 4.7% |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 3 filers · $97 total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 1 (-1 vs prior Q) | 1 (-1 vs prior Q) | 0 (0 vs prior Q) | 0 (-1 vs prior Q) | -17K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | $75 | 10 | 77.32% | Shares |
| UBS Group AG | $15 | 2 | 15.46% | Shares |
| SBI Securities Co., Ltd. | $7 | 1 | 7.22% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Agriculture Investment Group Corp. | April 7, 2026 | 65.10% | Initial filing | — | SEC |
| Union Group Ventures Limited, Union Group International Holdings Limited, Arvesa Corp, Juan Jose Sartori Pineyro ×2 filings | Feb. 25, 2025 | 37.80% | Amendment | — | SEC |
| The Biotech Company LLC, Gastón Paladini | April 17, 2024 | — | Initial filing | Passive investment | SEC |
| THEO I SCSp, Bioceres Group PLC | April 10, 2024 | — | Initial filing | — | SEC |
| BG Farming Technologies Limited, THEO I SCSp, Bioceres Group PLC | Jan. 9, 2023 | — | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.